MedTrace Logo

Clinical Trial of Thrombectomy Systems

NCT07749820 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 167

Last updated 2026-08-07

No results posted yet for this study

Summary

This study plans to enroll 167 subjects. Subject enrollment and treatment details will be documented, and follow-up assessments will be conducted at screening, on the procedure day, before discharge, and at 1, 3, and 6 months after the procedure, to assess the safety and efficacy of the peripheral thrombectomy system for the treatment of lower extremity deep vein thrombosis.

Conditions

  • Deep Vein Thrombosis (DVT)

Interventions

DEVICE

Peripheral thrombectomy system

For the subjects who met the requirements of the study protocol, the BM peripheral thrombectomy system was used for treatment.

Sponsors & Collaborators

  • BrosMed Medical Co., Ltd

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-30
Primary Completion
2027-12-30
Completion
2027-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07749820 on ClinicalTrials.gov